ELEV
NASDAQElevation Oncology Inc.
$0.37-0.01 (-2.49%)
Elevation Oncology Inc. (ELEV) is a Biotechnology: Biological Products (No Diagnostic Substances) company listed on NASDAQ. There were no new wire items for ELEV in the last 30 days. The most recent was published Aug 4, 2025.
Latest news
25 items- SECSEC Form 15-12G filed by Elevation Oncology Inc.15-12G - Elevation Oncology, Inc. (0001783032) (Filer)
- SECSEC Form EFFECT filed by Elevation Oncology Inc.EFFECT - Elevation Oncology, Inc. (0001783032) (Filer)
- SECSEC Form EFFECT filed by Elevation Oncology Inc.EFFECT - Elevation Oncology, Inc. (0001783032) (Filer)
- SECAmendment: SEC Form SCHEDULE 13D/A filed by Elevation Oncology Inc.SCHEDULE 13D/A - Elevation Oncology, Inc. (0001783032) (Subject)
- INSIDERSEC Form 4 filed by Director Sandler Alan B.4 - Elevation Oncology, Inc. (0001783032) (Issuer)
- INSIDERSEC Form 4 filed by Director Mootz Darcy4 - Elevation Oncology, Inc. (0001783032) (Issuer)
- INSIDERSEC Form 4 filed by Director Elms Steve4 - Elevation Oncology, Inc. (0001783032) (Issuer)
- INSIDERSEC Form 4 filed by Director Clackson Timothy P4 - Elevation Oncology, Inc. (0001783032) (Issuer)
- INSIDERSEC Form 4 filed by Director Cherrington Julie M4 - Elevation Oncology, Inc. (0001783032) (Issuer)
- INSIDERSEC Form 4 filed by Director Carruthers R Michael4 - Elevation Oncology, Inc. (0001783032) (Issuer)
- INSIDERCHIEF FINANCIAL OFFICER Furlong Tammy closing all direct ownership in the company (SEC Form 4)4 - Elevation Oncology, Inc. (0001783032) (Issuer)
- SECSEC Form S-8 POS filed by Elevation Oncology Inc.S-8 POS - Elevation Oncology, Inc. (0001783032) (Filer)
- SECSEC Form S-8 POS filed by Elevation Oncology Inc.S-8 POS - Elevation Oncology, Inc. (0001783032) (Filer)
- SECSEC Form S-8 POS filed by Elevation Oncology Inc.S-8 POS - Elevation Oncology, Inc. (0001783032) (Filer)
- SECSEC Form S-8 POS filed by Elevation Oncology Inc.S-8 POS - Elevation Oncology, Inc. (0001783032) (Filer)
- SECSEC Form S-8 POS filed by Elevation Oncology Inc.S-8 POS - Elevation Oncology, Inc. (0001783032) (Filer)
- SECSEC Form POS AM filed by Elevation Oncology Inc.POS AM - Elevation Oncology, Inc. (0001783032) (Filer)
- SECSEC Form POS AM filed by Elevation Oncology Inc.POS AM - Elevation Oncology, Inc. (0001783032) (Filer)
- SECSEC Form 25-NSE filed by Elevation Oncology Inc.25-NSE - Elevation Oncology, Inc. (0001783032) (Subject)
- SECElevation Oncology Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits8-K - Elevation Oncology, Inc. (0001783032) (Filer)
- SECAmendment: SEC Form SC 14D9/A filed by Elevation Oncology Inc.SC 14D9/A - Elevation Oncology, Inc. (0001783032) (Subject)
- SECElevation Oncology Inc. filed SEC Form 8-K: Termination of a Material Definitive Agreement8-K - Elevation Oncology, Inc. (0001783032) (Filer)
- SECSEC Form SC 14D9 filed by Elevation Oncology Inc.SC 14D9 - Elevation Oncology, Inc. (0001783032) (Subject)
- SECSEC Form SC TO-T filed by Elevation Oncology Inc.SC TO-T - Elevation Oncology, Inc. (0001783032) (Subject)
- INSIDERCHIEF EXECUTIVE OFFICER Ferra Joseph J Jr converted options into 12,560 shares and covered exercise/tax liability with 4,627 shares, increasing direct ownership by 6% to 145,085 units (SEC Form 4)4 - Elevation Oncology, Inc. (0001783032) (Issuer)
ELEV FAQ
7 questionsWhat is the latest news on ELEV?
Quantisnow has not tracked any new filings, ratings or press releases for ELEV in the last 30 days. The most recent wire item was published on August 4, 2025.Where does ELEV stock trade?
Elevation Oncology Inc. (ELEV) is listed on NASDAQ.What sector and industry is ELEV in?
Elevation Oncology Inc. operates in the Health Care sector, Biotechnology: Biological Products (No Diagnostic Substances) industry.When did Elevation Oncology Inc. go public?
Elevation Oncology Inc. (ELEV) completed its IPO in 2021.What are analysts saying about ELEV?
Elevation Oncology Inc. has had 8 recent analyst actions on file. The most recent action was from Stephens: Equal-Weight with a $100.00 price target on 2025-03-24.What companies are similar to ELEV?
Notable peers in the same industry include AMGN (Amgen Inc.), GILD (Gilead Sciences Inc.), MRNA (Moderna Inc.), ARGX (argenx SE), RVMD (Revolution Medicines Inc.). Compare ELEV side-by-side with any of them on Quantisnow.How can I track ELEV on Quantisnow?
Quantisnow aggregates Elevation Oncology Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow ELEV to receive live email and push alerts on every new disclosure.